|
Catalog Number PRT-NG-25 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Atrial Fibrillation (1729); Fever (1858); Unspecified Infection (1930); Heart Block (4444)
|
Event Date 10/17/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
Clinical study: (b)(4)- vantage ide study - clinical name, patient site id: (b)(6).It was reported that on (b)(6) 2022, a 25mm portico valve was selected for implant using a small flexnav delivery system.During the procedure, after pre-balloon valvuloplasty and after the abbott device made contact, the patient experienced left bundle branch block.No intervention was done to treat the heart block.The patient has sinus rhythm.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.On (b)(6) 2022, the patient developed a fever and was diagnosed with an infection.Antibiotics were prescribed.It is believed that the infection is not related to the implanted device.On (b)(6)2022, electrocardiogram (ecg) showed that the patient was having intermediate atrial flutter.The patient was started on anticoagulant as treatment.On (b)(6) 2022, the patient was reported to be discharged.A healthcare professional has stated that they believe the patient has not experienced adverse health consequences due to the performance of the product.No additional information was provided.
|
|
Event Description
|
Clinical study: (b)(6) - vantage ide study - clinical name, patient site id: (b)(6).It was reported that on (b)(6) 2022, a 25mm portico valve was selected for implant using a small flexnav delivery system.During the procedure, after pre-balloon valvuloplasty and after the abbott device made contact, the patient experienced left bundle branch block.No intervention was done to treat the heart block.The patient has sinus rhythm.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.On (b)(6) 2022, the patient developed a fever and was diagnosed with an infection.Antibiotics were prescribed.It is believed that the infection is not related to the implanted device.On (b)(6) 2022, electrocardiogram (ecg) showed that the patient was having intermediate atrial flutter.The patient was started on anticoagulant as treatment.On (b)(6) 2022, the patient was reported to be discharged.A healthcare professional has stated that they believe the patient has not experienced adverse health consequences due to the performance of the product.Subsequent to the previously filed report, additional information was received that after the patient was diagnosed with a fever they were administered tazobactan and piperacillin.The patients fever was reduced.
|
|
Manufacturer Narrative
|
An event of left bundle branch block, fever and intermediate atrial flutter was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection.Operation was performed and the product met all specifications.Based on the available information, the root cause of the reported incident could not be conclusively determined.
|
|
Search Alerts/Recalls
|
|
|